Literature DB >> 20528773

Impaired muscle protein anabolic response to insulin and amino acids in heart failure patients: relationship with markers of immune activation.

Michael J Toth1, Martin M LeWinter, Philip A Ades, Dwight E Matthews.   

Abstract

Patients with chronic HF (heart failure) experience muscle atrophy during the course of the disease. The mechanisms underlying muscle atrophy in HF, however, are not understood. Thus we evaluated leg phenylalanine balance and kinetics in HF patients and controls following a brief fast (24 h) and under euglycaemic-hyperinsulinaemic-hyperaminoacidaemic conditions to determine whether HF increases muscle protein catabolism in response to nutritional deprivation and/or diminishes the anabolic response to meal-related stimuli (insulin and amino acids) and whether alterations in protein metabolism correlate to circulating cytokine levels. No differences in phenylalanine balance, rate of appearance or rate of disappearance were found between patients and controls under fasting conditions. However, the anabolic response to hyperinsulinaemia-hyperaminoacidaemia was reduced by more than 50% in patients compared with controls. The diminished anabolic response was due to reduced suppression of the leg phenylalanine appearance rate, an index of protein breakdown, in HF patients; whereas no group difference was found in the increase in the leg phenylalanine disappearance rate, an index of protein synthesis. The diminished responses of both phenylalanine balance and appearance rate to hyperinsulinaemia-hyperaminoacidaemia were related to greater circulating IL-6 (interleukin-6) levels. Our results suggest that, following a brief period of nutritional deprivation, HF patients demonstrate an impaired muscle protein anabolic response to meal-related stimuli, due to an inability to suppress muscle proteolysis, and that this diminished protein anabolic response correlates with markers of immune activation. The inability to stimulate muscle protein anabolism following periods of nutritional deficiency may contribute to muscle wasting in HF patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20528773      PMCID: PMC3032598          DOI: 10.1042/CS20100110

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  47 in total

1.  Determinants of insulin-stimulated glucose disposal in middle-aged, premenopausal women.

Authors:  M J Toth; C K Sites; W T Cefalu; D E Matthews; E T Poehlman
Journal:  Am J Physiol Endocrinol Metab       Date:  2001-07       Impact factor: 4.310

Review 2.  Inflammatory mediators and the failing heart: past, present, and the foreseeable future.

Authors:  Douglas L Mann
Journal:  Circ Res       Date:  2002-11-29       Impact factor: 17.367

3.  Differential regulation of skeletal muscle protein turnover by insulin and IGF-I after bacteremia.

Authors:  T C Vary; D Dardevet; J Grizard; L Voisin; C Buffiere; P Denis; D Breuille; C Obled
Journal:  Am J Physiol       Date:  1998-10

4.  Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study.

Authors:  Stefan D Anker; Abdissa Negassa; Andrew J S Coats; Rizwan Afzal; Philip A Poole-Wilson; Jay N Cohn; Salim Yusuf
Journal:  Lancet       Date:  2003-03-29       Impact factor: 79.321

5.  Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro.

Authors:  Jean-Philippe Bastard; Mustapha Maachi; Jeanne Tran Van Nhieu; Claude Jardel; Eric Bruckert; André Grimaldi; Jean-Jacques Robert; Jacqueline Capeau; Bernard Hainque
Journal:  J Clin Endocrinol Metab       Date:  2002-05       Impact factor: 5.958

6.  Acute moderate elevation of TNF-alpha does not affect systemic and skeletal muscle protein turnover in healthy humans.

Authors:  Anne Marie Petersen; Peter Plomgaard; Christian P Fischer; Tobias Ibfelt; Bente Klarlund Pedersen; Gerrit van Hall
Journal:  J Clin Endocrinol Metab       Date:  2008-10-14       Impact factor: 5.958

Review 7.  Muscle-derived interleukin-6: lipolytic, anti-inflammatory and immune regulatory effects.

Authors:  Bente Klarlund Pedersen; Adam Steensberg; Pernille Keller; Charlotte Keller; Christian Fischer; Natalie Hiscock; Gerrit van Hall; Peter Plomgaard; Mark A Febbraio
Journal:  Pflugers Arch       Date:  2003-02-18       Impact factor: 3.657

8.  Differential regulation of protein dynamics in splanchnic and skeletal muscle beds by insulin and amino acids in healthy human subjects.

Authors:  Jonas Nygren; K Sreekumaran Nair
Journal:  Diabetes       Date:  2003-06       Impact factor: 9.461

9.  Mechanisms underlying skeletal muscle weakness in human heart failure: alterations in single fiber myosin protein content and function.

Authors:  Mark S Miller; Peter Vanburen; Martin M Lewinter; Stewart H Lecker; Donald E Selby; Bradley M Palmer; David W Maughan; Philip A Ades; Michael J Toth
Journal:  Circ Heart Fail       Date:  2009-09-24       Impact factor: 8.790

10.  Blunting of insulin inhibition of proteolysis in legs of older subjects may contribute to age-related sarcopenia.

Authors:  Emilie A Wilkes; Anna L Selby; Philip J Atherton; Rekha Patel; Debbie Rankin; Ken Smith; Michael J Rennie
Journal:  Am J Clin Nutr       Date:  2009-09-09       Impact factor: 7.045

View more
  12 in total

Review 1.  Role of insulin in the regulation of human skeletal muscle protein synthesis and breakdown: a systematic review and meta-analysis.

Authors:  Haitham Abdulla; Kenneth Smith; Philip J Atherton; Iskandar Idris
Journal:  Diabetologia       Date:  2015-09-24       Impact factor: 10.122

2.  Resistance training alters skeletal muscle structure and function in human heart failure: effects at the tissue, cellular and molecular levels.

Authors:  Michael J Toth; Mark S Miller; Peter VanBuren; Nicholas G Bedrin; Martin M LeWinter; Philip A Ades; Bradley M Palmer
Journal:  J Physiol       Date:  2011-12-23       Impact factor: 5.182

3.  Skeletal muscle mitochondrial density, gene expression, and enzyme activities in human heart failure: minimal effects of the disease and resistance training.

Authors:  Michael J Toth; Mark S Miller; Kimberly A Ward; Philip A Ades
Journal:  J Appl Physiol (1985)       Date:  2012-03-29

Review 4.  Adiponectin: key role and potential target to reverse energy wasting in chronic heart failure.

Authors:  An M Van Berendoncks; Anne Garnier; Renée Ventura-Clapier; Viviane M Conraads
Journal:  Heart Fail Rev       Date:  2013-09       Impact factor: 4.214

Review 5.  Skeletal muscle protein metabolism in human heart failure.

Authors:  Damien M Callahan; Michael J Toth
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2013-01       Impact factor: 4.294

Review 6.  Mechanisms for cachexia in heart failure.

Authors:  Vincent Pureza; Viorel G Florea
Journal:  Curr Heart Fail Rep       Date:  2013-12

7.  The effects of resistance exercise training on macro- and micro-circulatory responses to feeding and skeletal muscle protein anabolism in older men.

Authors:  Bethan E Phillips; Philip J Atherton; Krishna Varadhan; Marie C Limb; Daniel J Wilkinson; Kim A Sjøberg; Kenneth Smith; John P Williams
Journal:  J Physiol       Date:  2015-05-14       Impact factor: 5.182

8.  A validation of the application of D(2)O stable isotope tracer techniques for monitoring day-to-day changes in muscle protein subfraction synthesis in humans.

Authors:  Daniel J Wilkinson; Martino V Franchi; Matthew S Brook; Marco V Narici; John P Williams; William K Mitchell; Nathaniel J Szewczyk; Paul L Greenhaff; Philip J Atherton; Kenneth Smith
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-12-31       Impact factor: 4.310

9.  Targeting anabolic impairment in response to resistance exercise in older adults with mobility impairments: potential mechanisms and rehabilitation approaches.

Authors:  Micah J Drummond; Robin L Marcus; Paul C Lastayo
Journal:  J Aging Res       Date:  2012-09-11

10.  Association of body mass index and visceral fat with aortic valve calcification and mortality after transcatheter aortic valve replacement: the obesity paradox in severe aortic stenosis.

Authors:  Jennifer Mancio; Paulo Fonseca; Bruno Figueiredo; Wilson Ferreira; Monica Carvalho; Nuno Ferreira; Pedro Braga; Alberto Rodrigues; Antonio Barros; Ines Falcao-Pires; Adelino Leite-Moreira; Vasco Gama Ribeiro; Nuno Bettencourt
Journal:  Diabetol Metab Syndr       Date:  2017-10-19       Impact factor: 3.320

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.